NEW YORK, Feb. 25, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Nuance Communications, Inc. (NASDAQ:NUAN), Fate Therapeutics, Inc. (NASDAQ:FATE), Hamilton Lane Inc. (NASDAQ:HLNE), InflaRx N.V. (NASDAQ:IFRX), Enerplus Corporation (NYSE:ERF), and ManTech International Corporation (NASDAQ:MANT), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

NUAN DOWNLOAD: http://Fundamental-Markets.com/register/?so=NUAN
FATE DOWNLOAD: http://Fundamental-Markets.com/register/?so=FATE
HLNE DOWNLOAD: http://Fundamental-Markets.com/register/?so=HLNE
IFRX DOWNLOAD: http://Fundamental-Markets.com/register/?so=IFRX
ERF DOWNLOAD: http://Fundamental-Markets.com/register/?so=ERF
MANT DOWNLOAD: http://Fundamental-Markets.com/register/?so=MANT

The new research reports from Fundamental Markets, available for free download at the links above, examine Nuance Communications, Inc. (NASDAQ:NUAN), Fate Therapeutics, Inc. (NASDAQ:FATE), Hamilton Lane Inc. (NASDAQ:HLNE), InflaRx N.V. (NASDAQ:IFRX), Enerplus Corporation (NYSE:ERF), and ManTech International Corporation (NASDAQ:MANT) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed February 22nd, 2019. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

For the three months ended December 31st, 2018 vs December 31st, 2017, Nuance Communications reported revenue of $493.65MM vs $447.22MM (up 10.38%) and analysts estimated basic earnings per share $0.07 vs $0.18 (down 61.11%). For the twelve months ended September 30th, 2018 vs September 30th, 2017, Nuance Communications reported revenue of $2,051.66MM vs $1,939.36MM (up 5.79%) and analysts estimated basic earnings per share -$0.55 vs -$0.52. Analysts expect earnings to be released on May 8th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.17. The estimated EPS forecast for the next fiscal year is $0.80 and is expected to report on November 18th, 2019.

For the three months ended September 30th, 2018 vs September 30th, 2017, Fate Therapeutics reported revenue of $1.03MM vs $1.03MM (unchanged) and analysts estimated basic earnings per share -$0.31 vs -$0.26. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Fate Therapeutics reported revenue of $4.11MM vs $4.40MM (down 6.72%) and analysts estimated basic earnings per share -$1.02 vs -$1.05. Analysts expect earnings to be released on March 4th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was -$0.29. The estimated EPS forecast for the next fiscal year is -$1.10 and is expected to report on March 4th, 2019.

For the three months ended December 31st, 2018 vs December 31st, 2017, Hamilton Lane reported revenue of $66.00MM vs $65.01MM (up 1.51%) and analysts estimated basic earnings per share $0.22 vs -$0.35. For the twelve months ended March 31st, 2018 vs March 31st, 2017, Hamilton Lane reported revenue of $244.03MM vs $179.82MM (up 35.71%) and analysts estimated basic earnings per share $0.94 vs $0.03 (up 3,033.33%). Analysts expect earnings to be released on June 6th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was $0.58. The estimated EPS forecast for the next fiscal year is $2.06 and is expected to report on June 6th, 2019.

For the three months ended September 30th, 2018 vs September 30th, 2017, Enerplus reported revenue of $244.56MM vs $129.14MM (up 89.37%) and analysts estimated basic earnings per share $0.27 vs $0.06 (up 379.25%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Enerplus reported revenue of $721.26MM vs $523.61MM (up 37.75%) and analysts estimated basic earnings per share $0.76 vs $1.32 (down 42.80%). Analysts expect earnings to be released on May 2nd, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.09. The estimated EPS forecast for the next fiscal year is $1.32 and is expected to report on February 28th, 2020.

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at [email protected].

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.